Kota V Ramana Selected Research

Endotoxins

1/2019	Endotoxin-Induced Uveitis in Rodents.
1/2017	Retraction notice to "Piceatannol Suppresses endotoxin-induced ocular inflammation in Rats" [International Immunopharmacology 17/2 (2013) 439 - 446].
10/2016	Retraction notice to "Piceatannol Suppresses endotoxin-induced ocular inflammation in Rats" [International Immunopharmacology 17/2 (2013) 439 - 446].
10/2013	Piceatannol suppresses endotoxin-induced ocular inflammation in rats.
1/2013	Endotoxin-induced uveitis in rodents.
6/2012	Antidiabetic drug metformin suppresses endotoxin-induced uveitis in rats.
3/2012	A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases.
11/2011	Inhibition of aldose reductase prevents endotoxin-induced inflammation by regulating the arachidonic acid pathway in murine macrophages.
10/2011	Aldose reductase deficiency protects from autoimmune- and endotoxin-induced uveitis in mice.
10/2011	Amelioration of experimental autoimmune uveoretinitis by aldose reductase inhibition in Lewis rats.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kota V Ramana Research Topics

Disease

28	Inflammation (Inflammations) 03/2021 - 02/2003
16	Colonic Neoplasms (Colon Cancer) 01/2019 - 10/2006
15	Diabetes Complications 01/2022 - 10/2002
15	Neoplasms (Cancer) 01/2021 - 10/2006
12	Uveitis 01/2022 - 10/2007
11	Hyperglycemia 01/2019 - 07/2002
7	Asthma (Bronchial Asthma) 01/2013 - 08/2009
5	Respiratory Hypersensitivity 01/2013 - 08/2009
5	Body Weight (Weight, Body) 06/2012 - 05/2004
4	Sepsis (Septicemia) 06/2010 - 10/2006
3	Colorectal Neoplasms (Colorectal Cancer) 12/2017 - 07/2007
3	Carcinogenesis 12/2014 - 04/2010
3	Cataract (Cataracts) 05/2011 - 07/2002
3	Macular Degeneration (Age-Related Maculopathy) 03/2011 - 01/2008
2	Hypoxia (Hypoxemia) 01/2019 - 07/2011
2	Cardiotoxicity 01/2018 - 01/2017
2	Cardiomyopathies (Cardiomyopathy) 01/2018 - 10/2006
2	Neoplasm Metastasis (Metastasis) 04/2013 - 08/2011
2	Metaplasia 01/2013 - 12/2010
2	Androgen-Insensitivity Syndrome (Testicular Feminization) 11/2011 - 10/2011
2	Aberrant Crypt Foci 05/2011 - 05/2009
2	Infections 06/2010 - 12/2009
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 12/2009 - 10/2006
1	COVID-19 01/2022
1	Endotoxemia 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Hypertrophy 01/2018
1	Intestinal Neoplasms (Intestinal Cancer) 01/2018
1	Intestinal Polyps 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Polyps 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Obesity 12/2014

Drug/Important Bio-Agent (IBA)

44	Aldehyde Reductase (Aldose Reductase)IBA 03/2021 - 10/2002
19	EndotoxinsIBA 01/2019 - 10/2006
18	CytokinesIBA 01/2019 - 02/2003
13	fidarestatIBA 03/2021 - 12/2010
12	polyolIBA 10/2013 - 10/2002
12	EnzymesIBA 10/2013 - 03/2003
9	Glucose (Dextrose)FDA LinkGeneric 12/2014 - 07/2002
9	NF-kappa B (NF-kB)IBA 05/2010 - 08/2002
8	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 10/2006
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2013 - 02/2003
7	AldehydesIBA 01/2019 - 05/2005
7	Proteins (Proteins, Gene)FDA Link 04/2013 - 05/2004
6	LipopolysaccharidesIBA 01/2019 - 11/2006
6	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2017 - 10/2009
6	LipidsIBA 01/2013 - 04/2007
5	Pharmaceutical PreparationsIBA 01/2021 - 06/2012
5	AntioxidantsIBA 01/2019 - 05/2004
5	Transcription Factors (Transcription Factor)IBA 05/2011 - 08/2002
4	benphothiamine (benfotiamine)IBA 01/2022 - 05/2009
4	Thiamine (Aneurin)FDA Link 01/2022 - 05/2009
4	ChemokinesIBA 01/2013 - 11/2006
4	AllergensIBA 01/2013 - 08/2009
4	ragweed pollenIBA 11/2011 - 08/2009
3	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2021 - 01/2017
3	AnthracyclinesIBA 03/2021 - 01/2017
3	3,3',4,5'-tetrahydroxystilbeneIBA 01/2017 - 10/2013
3	Epidermal Growth Factor (EGF)IBA 10/2013 - 04/2010
3	OvalbuminIBA 01/2013 - 10/2009
3	Glutathione (Reduced Glutathione)IBA 07/2011 - 10/2006
3	Dinoprostone (PGE2)FDA Link 07/2011 - 10/2006
2	Therapeutic UsesIBA 01/2021 - 06/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 07/2011
2	didyminIBA 01/2019 - 01/2018
2	FlavonoidsIBA 01/2019 - 01/2018
2	GlycosidesIBA 01/2019 - 01/2018
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019 - 07/2011
2	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 10/2010
2	Streptozocin (Streptozotocin)FDA Link 10/2017 - 04/2006
2	2-nonenalIBA 01/2014 - 04/2006
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 08/2011 - 10/2006
2	Small Interfering RNA (siRNA)IBA 07/2011 - 10/2006
2	Immunoglobulin E (IgE)IBA 05/2011 - 10/2009
2	MucinsIBA 05/2011 - 08/2009
2	NADP (NADPH)IBA 05/2011 - 04/2010
2	Aldo-Keto ReductasesIBA 05/2011 - 04/2010
2	AzoxymethaneIBA 05/2011 - 05/2009
2	Carotenoids (Carotene)IBA 03/2011 - 01/2008
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 07/2007 - 10/2006
2	Protein Kinase CIBA 03/2005 - 02/2003
1	Sirtuin 1IBA 01/2019
1	Synthetic DrugsIBA 01/2018
1	3-nitrotyrosineIBA 01/2018
1	InflammasomesIBA 10/2017
1	NLR ProteinsIBA 10/2017
1	aspalatoneIBA 01/2017
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2017
1	CateninsIBA 12/2014
1	SurvivinIBA 12/2014
1	TNF-Related Apoptosis-Inducing LigandIBA 10/2013
1	PolyphenolsIBA 10/2013
1	MicroRNAs (MicroRNA)IBA 10/2013
1	Death Domain ReceptorsIBA 10/2013
1	Free Radical ScavengersIBA 10/2013

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 03/2021 - 07/2011
5	Therapeutics 01/2019 - 07/2010
2	Lenses 05/2011 - 07/2002
2	Subcutaneous Injections 10/2010 - 10/2007